- Home
- TALO vs ARQT Comparison
TALO vs ARQT Comparison
Compare TALO & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALO
- ARQT
- Stock Information
- Founded
- TALO 2011
- ARQT 2016
- Country
- TALO United States
- ARQT United States
- Employees
- TALO N/A
- ARQT N/A
- Industry
- TALO Oil & Gas Production
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- TALO Energy
- ARQT Health Care
- Exchange
- TALO Nasdaq
- ARQT Nasdaq
- Market Cap
- TALO 1.5B
- ARQT 1.7B
- IPO Year
- TALO N/A
- ARQT 2020
- Fundamental
- Price
- TALO $9.36
- ARQT $13.82
- Analyst Decision
- TALO Buy
- ARQT Strong Buy
- Analyst Count
- TALO 8
- ARQT 6
- Target Price
- TALO $14.25
- ARQT $18.80
- AVG Volume (30 Days)
- TALO 3.0M
- ARQT 1.9M
- Earning Date
- TALO 08-06-2025
- ARQT 08-13-2025
- Dividend Yield
- TALO N/A
- ARQT N/A
- EPS Growth
- TALO N/A
- ARQT N/A
- EPS
- TALO 0.14
- ARQT N/A
- Revenue
- TALO $2,055,748,000.00
- ARQT $212,819,000.00
- Revenue This Year
- TALO N/A
- ARQT $61.15
- Revenue Next Year
- TALO N/A
- ARQT $37.98
- P/E Ratio
- TALO $64.45
- ARQT N/A
- Revenue Growth
- TALO 31.54
- ARQT 100.03
- 52 Week Low
- TALO $6.23
- ARQT $7.86
- 52 Week High
- TALO $12.71
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- TALO 66.13
- ARQT 50.73
- Support Level
- TALO $9.13
- ARQT $12.97
- Resistance Level
- TALO $9.72
- ARQT $13.84
- Average True Range (ATR)
- TALO 0.37
- ARQT 0.61
- MACD
- TALO 0.10
- ARQT 0.02
- Stochastic Oscillator
- TALO 81.66
- ARQT 51.64
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.